This brand name is authorized in Austria, Australia, Spain, Ireland, New Zealand
The drug MYCOSTATIN contains one active pharmaceutical ingredient (API):
1
Nystatin
UNII BDF1O1C72E - NYSTATIN
|
Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
MYCOSTATIN Oral suspension | Health Products Regulatory Authority (IE) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A07AA02 | Nystatin | A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 10854G |
Country: ES | Centro de informaciรณn online de medicamentos de la AEMPS | Identifier(s): 28262 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 57843, 60017 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 1619 |
ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.